During the recent session, Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares were 10.33 million, with the beta value of the company hitting 0.08. At the last check today, the stock’s price was $0.91, reflecting an intraday loss of -6.10% or -$0.05. The 52-week high for the SLXN share is $122.02, that puts it down -13308.79 from that peak though still a striking 37.36% gain since the share price plummeted to a 52-week low of $0.57. The company’s market capitalization is $7.87M, and the average trade volume was 3.10 million shares over the past three months.

Silexion Therapeutics Corp (NASDAQ:SLXN) trade information

Silexion Therapeutics Corp (SLXN) registered a -6.10% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.10% in intraday trading to $0.91, hitting a weekly high. The stock’s 5-day price performance is -1.68%, and it has moved by 0.58% in 30 days. Based on these gigs, the overall price performance for the year is -99.07%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -286.10%. While earnings are projected to return 96.51% in 2025, the next five years will return 63.05% per annum.

SLXN Dividends

Silexion Therapeutics Corp is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Silexion Therapeutics Corp (NASDAQ:SLXN)’s Major holders

Data provided on Oct 31, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 587.0 shares. This amounts to just over 0.03 percent of the company’s overall shares, with a $527.0 market value.